Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 7:31 pm Purchase | 13G | VERASTEM INC VSTM | ORBIMED ADVISORS LLC | 1,529,115 6.1% | 1,529,115 (New Position) | View |
| 2024-02-14 10:00 am Purchase | 13G | VERASTEM INC VSTM | VIKING GLOBAL INVESTORS LP | 2,531,829 9.99% | 1,211,173 (+91.71%) | View |
| 2024-02-14 09:20 am Purchase | 13G | VERASTEM INC VSTM | BIOTECHNOLOGY VALUE FUND L P | 2,617,402 9.99% | 2,617,402 (New Position) | View |
| 2024-02-13 5:01 pm Purchase | 13G | VERASTEM INC VSTM | Vivo Opportunity LLC | 1,538,461 6.1% | 1,538,461 (New Position) | View |
| 2024-02-02 09:49 am Purchase | 13G | VERASTEM INC VSTM | Soleus Capital Master Fund L.P. | 1,425,634 6.8% | 128,265 (+9.89%) | View |
| 2023-08-31 5:28 pm Purchase | 13G | VERASTEM INC VSTM | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,300,000 5.15% | 1,300,000 (New Position) | View |
| 2023-08-10 4:39 pm Sale | 13G | VERASTEM INC VSTM | BAKER BROS. ADVISORS LP | 0 0% | -1,345,192 (Position Closed) | View |
| 2023-07-27 4:30 pm Purchase | 13G | VERASTEM INC VSTM | Soleus Capital Master Fund L.P. | 1,297,369 5.1% | 1,297,369 (New Position) | View |
| 2023-06-22 5:46 pm Purchase | 13G | VERASTEM INC VSTM | Flynn James E | 1,538,461 6.1% | 1,538,461 (New Position) | View |
| 2023-06-12 4:37 pm Purchase | 13G | VERASTEM INC VSTM | BAKER BROS. ADVISORS LP | 1,345,192 8% | 1,345,192 (New Position) | View |
| 2023-06-05 5:00 pm Purchase | 13G | VERASTEM INC VSTM | VIKING GLOBAL INVESTORS LP | 1,320,656 7.9% | 1,320,656 (New Position) | View |
| 2023-02-14 5:16 pm Purchase | 13G | VERASTEM, INC. VSTM | ORBIMED ADVISORS LLC | 16,503,237 7.9% | 16,503,237 (New Position) | View |
| 2023-02-14 4:00 pm Purchase | 13G | VERASTEM, INC. VSTM | BAKER BROS. ADVISORS LP | 26,988,898 13.5% | 5,497,268 (+25.58%) | View |
| 2023-02-13 8:16 pm Purchase | 13G | VERASTEM, INC. VSTM | BIOTECHNOLOGY VALUE FUND L P | 20,094,466 9.99% | 1,588,308 (+8.58%) | View |
| 2022-07-08 4:57 pm Sale | 13G | VERASTEM, INC. VSTM | BlackRock Inc. BLK | 4,337,334 2.3% | -7,990,914 (-64.82%) | View |
| 2022-02-14 4:16 pm Purchase | 13G | VERASTEM, INC. VSTM | BAKER BROS. ADVISORS LP | 21,491,630 11.8% | 2,805,935 (+15.02%) | View |
| 2022-02-10 08:42 am Sale | 13G | VERASTEM, INC. VSTM | VANGUARD GROUP INC | 8,849,796 4.86% | -162,782 (-1.81%) | View |
| 2022-02-03 4:41 pm Sale | 13G | VERASTEM, INC. VSTM | BlackRock Inc. BLK | 12,328,248 6.8% | -1,163,468 (-8.62%) | View |
| 2022-01-10 4:52 pm Purchase | 13G | VERASTEM, INC. VSTM | BIOTECHNOLOGY VALUE FUND L P | 18,506,158 10.2% | 1,444,000 (+8.46%) | View |
| 2022-01-10 4:49 pm Purchase | 13G | VERASTEM, INC. VSTM | BIOTECHNOLOGY VALUE FUND L P | 17,062,158 9.4% | 5,881,164 (+52.60%) | View |